These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 8095179

  • 21. Enhancement of activities of anti-tumor drugs by dipyridamole against multidrug-resistant human hepatoma PLC/PRF/5 cells.
    Tatsuta T, Shimizu K, Nishimura T, Suzuki H.
    Anticancer Drug Des; 1991 Jul; 6(3):179-88. PubMed ID: 1678605
    [Abstract] [Full Text] [Related]

  • 22. Resistance to N-benzyladriamycin-14-valerate in mouse J774.2 cells: P-glycoprotein expression without reduced N-benzyladriamycin-14-valerate accumulation.
    Lothstein L, Sweatman TW, Dockter ME, Israel M.
    Cancer Res; 1992 Jun 15; 52(12):3409-17. PubMed ID: 1350753
    [Abstract] [Full Text] [Related]

  • 23. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance.
    Smith CD, Zilfou JT, Stratmann K, Patterson GM, Moore RE.
    Mol Pharmacol; 1995 Feb 15; 47(2):241-7. PubMed ID: 7870031
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A sensitive method for immunocytochemical detection of P-glycoprotein in multidrug-resistant human ovarian carcinoma cell lines.
    Chan HS, Bradley G, Thorner P, Haddad G, Gallie BL, Ling V.
    Lab Invest; 1988 Dec 15; 59(6):870-5. PubMed ID: 2904510
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Suppression of P-glycoprotein expression and multidrug resistance by DNA cross-linking agents.
    Ihnat MA, Lariviere JP, Warren AJ, La Ronde N, Blaxall JR, Pierre KM, Turpie BW, Hamilton JW.
    Clin Cancer Res; 1997 Aug 15; 3(8):1339-46. PubMed ID: 9815817
    [Abstract] [Full Text] [Related]

  • 31. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G, Lorico A, Sartorelli AC.
    Cancer Res; 1993 Nov 15; 53(22):5487-93. PubMed ID: 8106148
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Study of mdr1 antisense oligodeoxynucleotides on reversal of multidrug resistance in ovarian carcinoma cell line SKOV3].
    Tong Y, Pan L, Zhou S.
    Zhonghua Fu Chan Ke Za Zhi; 2000 Nov 15; 35(11):677-9. PubMed ID: 11218898
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol.
    Arora A, Seth K, Kalra N, Shukla Y.
    Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II.
    Campain JA, Padmanabhan R, Hwang J, Gottesman MM, Pastan I.
    J Cell Physiol; 1993 May 01; 155(2):414-25. PubMed ID: 8097746
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.